A Phase 1b, Open-Label, Safety, Tolerability, and Efficacy Study of HC-7366 in Combination with Belzutifan (WELIREGTM) in Patients with Locally Advanced (Inoperable) or Metastatic Renal Cell Carcinoma
Details
Age
Adult
Locations
CTRC Inpatient
Highlands Ranch Hospital
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Elaine Lam
Study ID
Protocol Number: 24-0745
More information available at ClinicalTrials.gov: NCT06234605
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers